Why the study?
Differences in structural, functional, and arrhythmic disease progression between exercise-induced arrhythmogenic cardiomyopathy (EiAC) and arrhythmogenic right ventricular cardiomyopathy (ARVC) are not well understood.
Does disease progression differ between exercise-induced arrhythmogenic cardiomyopathy (EiAC) and arrhythmogenic right ventricular cardiomyopathy (ARVC)?
Does disease progression differ between exercise-induced arrhythmogenic cardiomyopathy (EiAC) and arrhythmogenic right ventricular cardiomyopathy (ARVC)?
Despite stable right ventricular structure and function in EiAC compared to deteriorating function in ARVC, both populations have a similarly high incidence of ventricular arrhythmias, warranting close long-term follow-up.
No takes yet. Share an insight, caveat, or question.
EiAC patients require arrhythmia monitoring despite stable RV imaging; extends distinction from progressive ARVC but needs prospective confirmation.
Aaserud et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: